#Efficacy of Isotretinoin and Antihistamine versus Isotretinoin Alone in the Treatment of Moderate to Severe Acne: A Randomised Control Trial
1	1	0	8	Efficacy
1	2	9	11	of
1	3	12	24	Isotretinoin
1	4	25	28	and
1	5	29	42	Antihistamine
1	6	43	49	versus
1	7	50	62	Isotretinoin
1	8	63	68	Alone
1	9	69	71	in
1	10	72	75	the
1	11	76	85	Treatment
1	12	86	88	of
1	13	89	97	Moderate
1	14	98	100	to
1	15	101	107	Severe
1	16	108	112	Acne
1	17	112	113	:
1	18	114	115	A
1	19	116	126	Randomised
1	20	127	134	Control
1	21	135	140	Trial
#Background Acne vulgaris has considerable impact on physical and psychological health.
2	1	141	151	Background
2	2	152	156	Acne
2	3	157	165	vulgaris
2	4	166	169	has
2	5	170	182	considerable
2	6	183	189	impact
2	7	190	192	on
2	8	193	201	physical
2	9	202	205	and
2	10	206	219	psychological
2	11	220	226	health
2	12	226	227	.
#Isotretinoin is considered most effective drug available for acne therapy but with limited acceptance because of its adverse effects.
3	1	315	327	Isotretinoin
3	2	328	330	is
3	3	331	341	considered
3	4	342	346	most
3	5	347	356	effective
3	6	357	361	drug
3	7	362	371	available
3	8	372	375	for
3	9	376	380	acne
3	10	381	388	therapy
3	11	389	392	but
3	12	393	397	with
3	13	398	405	limited
3	14	406	416	acceptance
3	15	417	424	because
3	16	425	427	of
3	17	428	431	its
3	18	432	439	adverse
3	19	440	447	effects
3	20	447	448	.
#Antihistamine inhibits inflammatory mediators, Propionibacterium acne induced itching, reduction of squalene and sebum in sebocyte, reduces anxiety and further lessens hormonal derangement and inhibits mast cell induced fibrosis and scars.
4	1	583	596	Antihistamine
4	2	597	605	inhibits
4	3	606	618	inflammatory
4	4	619	628	mediators
4	5	628	629	,
4	6	630	647	Propionibacterium
4	7	648	652	acne
4	8	653	660	induced
4	9	661	668	itching
4	10	668	669	,
4	11	670	679	reduction
4	12	680	682	of
4	13	683	691	squalene
4	14	692	695	and
4	15	696	701	sebum
4	16	702	704	in
4	17	705	713	sebocyte
4	18	713	714	,
4	19	715	722	reduces
4	20	723	730	anxiety
4	21	731	734	and
4	22	735	742	further
4	23	743	750	lessens
4	24	751	759	hormonal
4	25	760	771	derangement
4	26	772	775	and
4	27	776	784	inhibits
4	28	785	789	mast
4	29	790	794	cell
4	30	795	802	induced
4	31	803	811	fibrosis
4	32	812	815	and
4	33	816	821	scars
4	34	821	822	.
#Clinical relevance is lacking in the use of antihistamine in the treatment of acne and its potential efficacy needs to be clarified.
5	1	1063	1071	Clinical
5	2	1072	1081	relevance
5	3	1082	1084	is
5	4	1085	1092	lacking
5	5	1093	1095	in
5	6	1096	1099	the
5	7	1100	1103	use
5	8	1104	1106	of
5	9	1107	1120	antihistamine
5	10	1121	1123	in
5	11	1124	1127	the
5	12	1128	1137	treatment
5	13	1138	1140	of
5	14	1141	1145	acne
5	15	1146	1149	and
5	16	1150	1153	its
5	17	1154	1163	potential
5	18	1164	1172	efficacy
5	19	1173	1178	needs
5	20	1179	1181	to
5	21	1182	1184	be
5	22	1185	1194	clarified
5	23	1194	1195	.
#Objective To evaluate the efficacy and safety of combining isotretinoin and antihistamine compare to isotretinoin alone in patients with moderate to severe acne at week 12.
6	1	1329	1338	Objective
6	2	1339	1341	To
6	3	1342	1350	evaluate
6	4	1351	1354	the
6	5	1355	1363	efficacy
6	6	1364	1367	and
6	7	1368	1374	safety
6	8	1375	1377	of
6	9	1378	1387	combining
6	10	1388	1400	isotretinoin
6	11	1401	1404	and
6	12	1405	1418	antihistamine
6	13	1419	1426	compare
6	14	1427	1429	to
6	15	1430	1442	isotretinoin
6	16	1443	1448	alone
6	17	1449	1451	in
6	18	1452	1460	patients
6	19	1461	1465	with
6	20	1466	1474	moderate
6	21	1475	1477	to
6	22	1478	1484	severe
6	23	1485	1489	acne
6	24	1490	1492	at
6	25	1493	1497	week
6	26	1498	1500	12
6	27	1500	1501	.
#Method One hundred patients with moderate to severe acne were included in this randomised, controlled comparative study.
7	1	1675	1681	Method
7	2	1682	1685	One
7	3	1686	1693	hundred
7	4	1694	1702	patients
7	5	1703	1707	with
7	6	1708	1716	moderate
7	7	1717	1719	to
7	8	1720	1726	severe
7	9	1727	1731	acne
7	10	1732	1736	were
7	11	1737	1745	included
7	12	1746	1748	in
7	13	1749	1753	this
7	14	1754	1764	randomised
7	15	1764	1765	,
7	16	1766	1776	controlled
7	17	1777	1788	comparative
7	18	1789	1794	study
7	19	1794	1795	.
#Fifty patients were treated with isotretinoin and 50 patients were treated with additional antihistamine, levocetirizine and assessment was done at baseline, 4, 8 and 12 weeks of treatment.
8	1	1917	1922	Fifty
8	2	1923	1931	patients
8	3	1932	1936	were
8	4	1937	1944	treated
8	5	1945	1949	with
8	6	1950	1962	isotretinoin
8	7	1963	1966	and
8	8	1967	1969	50
8	9	1970	1978	patients
8	10	1979	1983	were
8	11	1984	1991	treated
8	12	1992	1996	with
8	13	1997	2007	additional
8	14	2008	2021	antihistamine
8	15	2021	2022	,
8	16	2023	2037	levocetirizine
8	17	2038	2041	and
8	18	2042	2052	assessment
8	19	2053	2056	was
8	20	2057	2061	done
8	21	2062	2064	at
8	22	2065	2073	baseline
8	23	2073	2074	,
8	24	2075	2076	4
8	25	2076	2077	,
8	26	2078	2079	8
8	27	2080	2083	and
8	28	2084	2086	12
8	29	2087	2092	weeks
8	30	2093	2095	of
8	31	2096	2105	treatment
8	32	2105	2106	.
#Result At week 12, compared to isotretinoin only group, combination of isotretinoin and levocetirizine group showed more statistically significant decrease in score of global acne grading system (51.0 vs. 38.5%) and acne lesion counts (non-inflammatory lesion: 63.2 vs. 44.5%; inflammatory lesions: 75.9 vs. 62.7%; total lesions: 66.07 vs. 48.7%; all p< 0.05).
9	1	2297	2303	Result
9	2	2304	2306	At
9	3	2307	2311	week
9	4	2312	2314	12
9	5	2314	2315	,
9	6	2316	2324	compared
9	7	2325	2327	to
9	8	2328	2340	isotretinoin
9	9	2341	2345	only
9	10	2346	2351	group
9	11	2351	2352	,
9	12	2353	2364	combination
9	13	2365	2367	of
9	14	2368	2380	isotretinoin
9	15	2381	2384	and
9	16	2385	2399	levocetirizine
9	17	2400	2405	group
9	18	2406	2412	showed
9	19	2413	2417	more
9	20	2418	2431	statistically
9	21	2432	2443	significant
9	22	2444	2452	decrease
9	23	2453	2455	in
9	24	2456	2461	score
9	25	2462	2464	of
9	26	2465	2471	global
9	27	2472	2476	acne
9	28	2477	2484	grading
9	29	2485	2491	system
9	30	2492	2493	(
9	31	2493	2497	51.0
9	32	2498	2501	vs.
9	33	2502	2506	38.5
9	34	2506	2507	%
9	35	2507	2508	)
9	36	2509	2512	and
9	37	2513	2517	acne
9	38	2518	2524	lesion
9	39	2525	2531	counts
9	40	2532	2533	(
9	41	2533	2549	non-inflammatory
9	42	2550	2556	lesion
9	43	2556	2557	:
9	44	2558	2562	63.2
9	45	2563	2566	vs.
9	46	2567	2571	44.5
9	47	2571	2572	%
9	48	2572	2573	;
9	49	2574	2586	inflammatory
9	50	2587	2594	lesions
9	51	2594	2595	:
9	52	2596	2600	75.9
9	53	2601	2604	vs.
9	54	2605	2609	62.7
9	55	2609	2610	%
9	56	2610	2611	;
9	57	2612	2617	total
9	58	2618	2625	lesions
9	59	2625	2626	:
9	60	2627	2632	66.07
9	61	2633	2636	vs.
9	62	2637	2641	48.7
9	63	2641	2642	%
9	64	2642	2643	;
9	65	2644	2647	all
9	66	2648	2649	p
9	67	2649	2650	<
9	68	2651	2655	0.05
9	69	2655	2656	)
9	70	2656	2657	.
#Flaring up of acne occurred less frequently and adverse effects were more tolerable in levocetirizine group.
10	1	3019	3026	Flaring
10	2	3027	3029	up
10	3	3030	3032	of
10	4	3033	3037	acne
10	5	3038	3046	occurred
10	6	3047	3051	less
10	7	3052	3062	frequently
10	8	3063	3066	and
10	9	3067	3074	adverse
10	10	3075	3082	effects
10	11	3083	3087	were
10	12	3088	3092	more
10	13	3093	3102	tolerable
10	14	3103	3105	in
10	15	3106	3120	levocetirizine
10	16	3121	3126	group
10	17	3126	3127	.
#Conclusion Use of antihistamine with isotretinoin provides synergic effect while minimizing the side effect of isotretinoin and greater clearance of the lesion and scars.
11	1	3237	3247	Conclusion
11	2	3248	3251	Use
11	3	3252	3254	of
11	4	3255	3268	antihistamine
11	5	3269	3273	with
11	6	3274	3286	isotretinoin
11	7	3287	3295	provides
11	8	3296	3304	synergic
11	9	3305	3311	effect
11	10	3312	3317	while
11	11	3318	3328	minimizing
11	12	3329	3332	the
11	13	3333	3337	side
11	14	3338	3344	effect
11	15	3345	3347	of
11	16	3348	3360	isotretinoin
11	17	3361	3364	and
11	18	3365	3372	greater
11	19	3373	3382	clearance
11	20	3383	3385	of
11	21	3386	3389	the
11	22	3390	3396	lesion
11	23	3397	3400	and
11	24	3401	3406	scars
11	25	3406	3407	.
